Harmony Biosciences appoints Anastasiou as Chief Operating Officer

Harmony Biosciences (HRMY) announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Directors, including the appointment of Troy Ignelzi as a director and the nomination of Geno Germano as a director for election at Harmony’s 2026 Annual Meeting of Shareholders. Anastasiou previously served on Harmony Biosciences’ Board of Directors, where he contributed strategic insight across the business during a period of continued growth and operational evolution. He brings more than three decades of experience building and leading biotechnology organizations. Most recently, Anastasiou served as Chief Executive Officer of Capsida Biotherapeutics. In connection with his appointment as Chief Operating Officer, Anastasiou resigned from the Board.